Skip to main content
. Author manuscript; available in PMC: 2007 Oct 1.
Published in final edited form as: J Mol Biol. 2007 Mar 12;369(1):69–78. doi: 10.1016/j.jmb.2007.03.002

Table 2.

Expression of ST6GalNAcI and II mRNA in EBV-immortalized B cells measured by RealTime RT-PCR.

IgAN patients* Healthy controls
ST6-GalNAcI N/D N/D
ST6-GalNAcII 2.68 ± 0.11 1.97 ± 0.44
*

Data are presented as mean ± SD of crossing points normalized to the crossing points of β-actin, measured by RealTime RT-PCR. IgA1-producing B cells were generated from 4 patients with IgAN (total of 7 different clones) and 4 healthy controls (total of 7 different clones). The difference in the expression of ST6GalNAcII in the cells from IgAN patients and healthy controls was statistically significant, P < 0.01. N/D, not detected.